IOL Chemicals and Pharmaceuticals Limited
Polunin Emerging Markets Small Cap Fund bought 44.19 lakh shares of IOL Chemicals and Pharmaceuticals for ₹73.65 Cr at ₹166.65 apiece in a bulk deal.
A leading pharmaceutical company, IOL Chemicals manufactures active pharmaceutical ingredients and specialty chemicals for both domestic and international markets. The company serves pharmaceutical manufacturers, agrochemical producers, and other industrial clients across multiple sectors. Its integrated operations span chemical synthesis, process development, quality assurance, and regulatory compliance. IOL Chemicals maintains manufacturing facilities equipped with advanced technology to ensure product quality and consistency across its diverse portfolio.
An institutional long-only emerging-markets small-cap fund managed by London-based Polunin Capital Partners. The strategy launched in 2007 and uses a valuation-driven, contrarian process to find mispriced cyclical businesses. Polunin manages about £5.8 billion across five funds and separately managed accounts.